Drug firm Wockhardt on Tuesday reported a consolidated net loss of Rs 177 crore for the fourth quarter ended March 31, 2024. The company had reported a net loss of Rs 237 crore in the January-March quarter of 2022-23.
Revenue from operations stood at Rs 700 crore for the period under review as compared with Rs 678 crore in the same period of FY23, the Mumbai-based drugmaker said in a regulatory filing.
For the year ended March 31, 2024, the company reported a net loss of Rs 472 crore against a net loss of Rs 621 crore in 2022-23 fiscal.
Revenue from operations increased to Rs 2,798 crore in FY24 compared with Rs 2,651 crore in FY23.
The company said its board approved the re-appointment of Habil Khorakiwala as Executive Chairman for a further term of five years with effect from March 1, 2025, to Feb. 28, 2030.
Shares of the company on Tuesday ended 0.49% down at Rs 557.95 apiece on the BSE.
RECOMMENDED FOR YOU
Wockhardt Aims To Regain Rs 5,000-Crore Revenue In Three Years, Says Chairperson Khorakiwala
Jun 04, 2025
Vodafone Idea Q4 Results: Loss Widens To Rs 7,166 Crore, ARPU Flat
May 31, 2025
Coffee Day Q4 Results: Net Loss Narrows To Rs 114 Crore, Revenue Up 7%
May 30, 2025
Wockhardt Q4 Results: Net Loss Narrows As Ebitda Turns Positive
May 29, 2025
POPULAR